chalcone has been researched along with Cirrhosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adelusi, T; Chowdhry, A; Du, L; Gu, X; Hao, M; Li, X; Lu, Q; Sun, Y; Xu, L; Yin, X; Zhou, X | 1 |
| Chavasiri, W; Danova, A; Jutabha, P; Muanprasat, C; Noitem, R; Poolsri, W; Raveesunthornkiat, M | 1 |
| Hseu, YC; Lee, CC; Li, ML; Lin, RW; Mathew, DC; Rajendran, P; Tsai, CH; Yang, HL; Yang, TY | 1 |
| Chu, J; Duan, J; Hu, N; Li, H; Liu, M; Lu, C; Sun, J; Wang, C; Wang, F; Wang, Y; Wen, A | 1 |
4 other study(ies) available for chalcone and Cirrhosis
| Article | Year |
|---|---|
Novel Chalcone BDD-39 Mitigated Diabetic Nephropathy through the Activation of Nrf2/ARE Signaling.
Topics: Animals; Biphenyl Compounds; Chalcone; Chalcones; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fibrosis; Mice; NF-E2-Related Factor 2; Oxidative Stress; RNA; Signal Transduction | 2022 |
Discovery of a chalcone derivative as an anti-fibrotic agent targeting transforming growth factor-β1 signaling: Potential therapy of renal fibrosis.
Topics: Animals; Antifibrotic Agents; Chalcone; Chalcones; Fibrosis; Kidney; Kidney Diseases; Mice; Renal Insufficiency, Chronic; Transforming Growth Factor beta1; Ureteral Obstruction | 2023 |
Chalcone flavokawain A attenuates TGF-β1-induced fibrotic pathology via inhibition of ROS/Smad3 signaling pathways and induction of Nrf2/ARE-mediated antioxidant genes in vascular smooth muscle cells.
Topics: Actins; Animals; Antioxidant Response Elements; Antioxidants; Aorta; Cell Line; Cell Movement; Chalcone; Fibronectins; Fibrosis; Gene Expression Regulation; Heme Oxygenase-1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Models, Biological; Myocytes, Smooth Muscle; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Rats; Reactive Oxygen Species; Signal Transduction; Smad3 Protein; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1 | 2019 |
Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
Topics: Animals; Apoptosis; Blood Urea Nitrogen; Cell Proliferation; Chalcone; Creatinine; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fibrosis; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Quinones; Smad3 Protein; Transforming Growth Factor beta1; Ureteral Obstruction | 2016 |